News

Washington Times2y
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use
WASHINGTON — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug ... begin covering the drug if it gets FDA’s full OK.
Fox News1y
Experimental Alzheimer’s drug gets FDA advisory panel's thumbs-up: ‘Progress is happening’
An experimental Alzheimer’s drug, donanemab, was endorsed by a U.S. Food and Drug Administration (FDA) advisory panel on Monday. Donanemab is designed to treat symptoms of early Alzheimer’s ...
Detroit News2y
Alzheimer's drug gets FDA panel's backing, setting the stage for broader use
Washington – Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug ... begin covering the drug if it gets FDA’s full OK.
News4Jax2y
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use
On Friday, June 9, 2023, health advisers backed the full approval of the closely watched Alzheimers drug ... immediately begin covering the drug if it gets FDA’s full OK. But last week she ...
KPLC2y
Alzheimer’s drug gets FDA panel’s backing, setting the stage for broader use
WASHINGTON (AP) — Health advisers on Friday unanimously backed the full approval of a closely watched Alzheimer’s drug, a key step toward opening ... will immediately begin covering the drug if it ...